Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| One-shot Learning from Demonstration Approach Toward a Reciprocal Sign Language-based HRI. | Int J Soc Robot | 2021 | 34394771 | PubTator, text mining | PubMed |
| Genetic basis of pulmonary arterial hypertension: a prospective study from a highly inbred population. | Pulm Circ | 2021 | 34377436 | PubTator, text mining | PubMed |
| Temporal pattern and synergy influence activity of ERK signaling pathways during L-LTP induction. | Elife | 2021 | 34374340 | PubTator, text mining | PubMed |
| Systematic Bioinformatic Analyses of Nutrigenomic Modifications by Polyphenols Associated with Cardiometabolic Health in Humans-Evidence from Targeted Nutrigenomic Studies. | Nutrients | 2021 | 34371836 | PubTator, text mining | PubMed |
| A Comprehensive Overview of circRNAs: Emerging Biomarkers and Potential Therapeutics in Gynecological Cancers. | Front Cell Dev Biol | 2021 | 34368160 | PubTator, text mining | PubMed |
| Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype. | Biomed J | 2021 | 34366294 | PubTator, text mining | PubMed |
| Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. | J Clin Med | 2021 | 34362022 | PubTator, text mining | PubMed |
| High-Density Lipoproteins in Kidney Disease. | Int J Mol Sci | 2021 | 34360965 | PubTator, text mining | PubMed |
| The RHO Family GTPases: Mechanisms of Regulation and Signaling. | Cells | 2021 | 34359999 | PubTator, text mining | PubMed |
| An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma. | Int J Gen Med | 2021 | 34354370 | PubTator, text mining | PubMed |
| Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma. | Oncoimmunology | 2021 | 34350060 | PubTator, text mining | PubMed |
Prospective, Randomized, Open-Label, Blinded End Point, Two-Arm, Comparative Clinical Study to Evaluate the Efficacy and Safety of a Fixed Ayurvedic Regimen (FAR) as Add-on to Conventional Treatment in the Management of Mild and Moderate COVID-19 Patients. | J Pharm Bioallied Sci | 2021 | 34349488 | PubTator, text mining | PubMed |
| A case of capillary malformation-arteriovenous malformation and Ebstein's anomaly in a child with EphB4 mutation. | Pediatr Dermatol | 2021 | 34339071 | PubTator, text mining | PubMed |
| Chatbots as a Tool to Scale Mentoring Processes: Individually Supporting Self-Study in Higher Education. | Front Artif Intell | 2021 | 34337393 | PubTator, text mining | PubMed |
| Genetic syndromes with vascular malformations - update on molecular background and diagnostics. | Arch Med Sci | 2021 | 34336026 | PubTator, text mining | PubMed |
| Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot. | Circ Genom Precis Med | 2021 | 34328347 | PubTator, text mining | PubMed |
| Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML. | J Immunother Cancer | 2021 | 34326171 | PubTator, text mining | PubMed |
| Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. | BMC Pediatr | 2021 | 34325699 | PubTator, text mining | PubMed |
| Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19. | J Med Microbiol | 2021 | 34313585 | PubTator, text mining | PubMed |
| MUSTARD-a comprehensive resource of mutation-specific therapies in cancer. | Database (Oxford) | 2021 | 34309639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=46